FMR CORP 13D and 13G filings for Apogee Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 09:50 am Purchase |
2024-11-08 | 13G | Apogee Therapeutics, Inc. APGE |
FMR CORP | 7,502,482 16.672% |
2,483,602 (+49.49%) |
Filing |
| 2024-02-09 08:35 am Purchase |
2024-02-08 | 13G | Apogee Therapeutics, Inc. APGE |
FMR CORP | 5,018,880 13.496% |
570,979 (+12.84%) |
Filing |
| 2023-08-10 08:19 am Purchase |
2023-08-09 | 13G | Apogee Therapeutics, Inc. APGE |
FMR CORP | 4,447,901 12.094% |
4,447,901 (New Position) |
Filing |